Latest News - Stryker Corporation
Top Corporates Hub
Stryker Corporation
SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up
01.08.2025 12:50
SYK's second-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker raises 2025 outlook amid 17.3% medical surgery and neurotechnology unit rise
01.08.2025 11:42
Stryker’s vascular segment reached $498m in Q2 2025, more than doubling its financial performance in Q2 2024.
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges
01.08.2025 07:35
Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year guidance despite ongoing supply chain issues.
Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases
29.07.2025 13:07
Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal.
Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?
29.07.2025 12:54
Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.
Tumor Ablation Market Research Report 2025-2032 | Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments
18.07.2025 11:02
The global tumor ablation market is projected to surge from USD 1.67 billion in 2024 to USD 4.15 billion by 2032. Driven by advancements in minimally invasive techniques like radiofrequency and microwave, the market benefits from precision treatments aligned with the rise of personalized medicine. Key players include AngioDynamics and Stryker.Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Tumor Ablation Market (By Technology, Treatment Mode, Application, End-User, Regional Analysis), Company Pro
Surgical stroke initiative targets deadliest brain bleeds
14.07.2025 14:00
(NewMediaWire) - July 14, 2025 - DALLAS Hemorrhagic strokes account for just 13% of the nearly 800,000 strokes that occur in the U.S. each year, yet they are responsible for more than 40% of all stroke-related deaths.[1] These devastating brain blee...
Blood Lead Analyzer Market Outlook 2025-2034 | Stryker Launches Advanced Pediatric ESIN Systems, Orthofix and Smith & Nephew Follow Suit
10.07.2025 13:28
Explore the booming Blood Lead Analyzer market, valued at USD 271.1 million in 2024 and projected to hit USD 430.1 million by 2032. Discover trends, growth drivers, and key player strategies, alongside market forecasts for various regions. Stay ahead with insights into industry challenges and opportunities. Blood Lead Analyzer Market Blood Lead Analyzer Market Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "Blood Lead Analyzer Market Outlook 2025-2034: Market Share, and Growth Analysis By Applica
What to Expect From Stryker's Next Quarterly Earnings Report
10.07.2025 11:53
Stryker will release its second-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.
Stryker to announce financial results for its second quarter of fiscal year 2025
01.07.2025 12:00
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, July 31, 2025, to d
J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?
26.06.2025 13:40
JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.
FDA grants 510(k) clearance to Stryker’s total ankle system
26.06.2025 09:12
The system features Adaptis Boney Ingrowth Technology and redesigned instrumentation.
Stryker receives FDA clearance for Incompass Total Ankle System
25.06.2025 12:15
PORTAGE, Mich., June 25, 2025--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.
Stryker (SYK): Buy, Sell, or Hold Post Q1 Earnings?
16.06.2025 04:04
Since December 2024, Stryker has been in a holding pattern, posting a small return of 1.1% while floating around $376.76.
There May Be Reason For Hope In Stryker's (NYSE:SYK) Disappointing Earnings
13.05.2025 12:05
The market for Stryker Corporation's ( NYSE:SYK ) shares didn't move much after it posted weak earnings recently. Our...